middle.news
EBR Systems Q1 2026: WiSE implants double, US$2.4M revenue, TGA priority review granted, but net loss widens
9:20am on Tuesday 12th of May, 2026 AEST
•
Healthcare
Read Story
EBR Systems Q1 2026: WiSE implants double, US$2.4M revenue, TGA priority review granted, but net loss widens
9:20am on Tuesday 12th of May, 2026 AEST
Key Points
WiSE implants more than doubled to 41 in Q1 2026
Q1 revenue reached US$2.4 million amid Limited Market Release
TGA granted Priority Review for accelerated Australian approval
Net loss widened to US$17.1 million with increased cash burn
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Ebr Systems (ASX:EBR)
OPEN ARTICLE